Developer docs
API playgroundTry for free, no card

Search company profiles

Montreal Heart Institute

Full company profile

uuid0009iwf

Namestring
Montreal Heart Institute
Websiteurl
icm-mhi.org
Company typeenum
Private
Founded yearint
1954
Descriptiontext

The Montreal Heart Institute (MHI) is a specialty cardiac hospital founded in 1954 in Montreal, Quebec, Canada, focused exclusively on cardiology, structural heart intervention, and cardiovascular research. It serves three primary customer segments: valve disease and structural heart patients receiving direct clinical care; international heart surgeons and specialists trained at its newly opened Advanced Simulation Centre; and women with cardiovascular health needs served through its dedicated Women's Heart Health Fund.

MHI's core offerings span three pillars. First, clinical care services including structural heart and valve therapy, cardiac imaging diagnostics, and emergency cardiac care delivered directly through its Montreal hospital facility. Second, specialist training via the Advanced Simulation Centre for Structural Heart and Valve Therapy — the first such facility in the Americas — which uses high-fidelity Simulands cardiovascular simulation systems to train 40-50 international specialists annually without patient risk. Third, research and innovation, notably a multiview deep neural network architecture co-developed with UCSF for echocardiogram analysis, published in Nature Cardiovascular Research, which demonstrated superior diagnostic accuracy versus single-view AI approaches.

MHI's business model is primarily a fee-for-service healthcare provider operating within the Quebec healthcare system, supplemented by philanthropic fundraising through the Montreal Heart Institute Foundation (including the $25M Women's Heart Health Fund target by 2030) and academic/government research grants. Revenue model details are not publicly disclosed, consistent with a healthcare institution. The institute distributes services regionally to patients in Quebec and globally through its international training program. MHI holds a "for-profit" classification in source data but functions as a specialty hospital with associated foundation-driven fundraising.

Short descriptiontext

The Montreal Heart Institute is a Montreal-based specialty cardiac hospital founded in 1954 that delivers clinical cardiology, structural heart interventions, and international specialist training through its first-in-Americas Advanced Simulation Centre, while conducting AI cardiac imaging research with UCSF.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersMontréal, Canada
HQ citystring
Montréal
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cardiac care services, structural heart therapy, cardiovascular research, specialist medical training, cardiac imaging diagnostics
Industry7 codes
1Cardiac & Cardiothoracic Specialty Hospitals
CodeHLAFAHAAPrimaryYes
2Interventional Cardiology (PCI/Structural Heart)
CodeHLAKABABPrimaryNo
3Non-Invasive Cardiac Imaging (Echo/CT/MRI/Nuclear)
CodeHLAKABAEPrimaryNo
4Cardiovascular / Cath Lab & Electrophysiology Centers
CodeHLAFAIAIPrimaryNo
5Ambulatory Cardiology Diagnostic & Procedure Centers (Non-hospital-based)
CodeHLAFABAKPrimaryNo
6Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT)
CodeHLAHAFAIPrimaryNo
7General Cardiology (Consultative)
CodeHLAKABAAPrimaryNo
NAICS code2 codes
  • Specialty (except Psychiatric and Substance Abuse) Hospitals622310
  • Diagnostic Imaging Centers621512
SIC code3 codes
  • Services-Hospitals8060
  • Services-Offices & Clinics Of Doctors Of Medicine8011
  • Services-General Medical & Surgical Hospitals, Nec8062
Product category
Specialty Cardiac Hospital Services
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Others
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Montreal Heart Institute is a specialty cardiac hospital founded in 1954 that delivers comprehensive cardiovascular care, structural heart and valve therapy, and operates the first Advanced Simulation Centre for Structural Heart and Valve Therapy in the Americas for training heart specialists. The institute also conducts AI-driven cardiac imaging research through a multiview deep neural network developed in collaboration with UCSF, and channels donor funding through its foundation into clinical innovation for women's heart health.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 20% increase in cardiac-related emergency cases during playoff games
+2 more records
Product overview1 text field

The Montreal Heart Institute is a cardiac care and research center that offers specialized medical services including cardiac imaging diagnostics, structural heart and valve therapy, and cardiovascular research. The institution operates the Advanced Simulation Centre for Structural Heart and Valve Therapy (first in the Americas) for specialist training, and conducts AI research collaboration for cardiac imaging analysis. The Montreal Heart Institute Foundation supports the Women's Heart Health Fund for women's cardiovascular care research and treatment. The portfolio consists of clinical care services, specialized training facilities, and AI-powered diagnostic tools.

Product and service1 record
1Cardiac Care Services
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-02-27
Description

Zurich-based Simulands provides high-fidelity cardiovascular simulation systems for the Advanced Simulation Centre for Structural Heart and Valve Therapy at MHI. This technology enables immersive training for specialists in structural heart interventions without risk to patients.

2UC San Francisco
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaborative research partnership with UCSF on developing multiview deep neural network architecture for cardiac imaging analysis. The study published in Nature Cardiovascular Research compared data from both institutions, with MHI providing cardiac imaging data to validate the AI diagnostic approach.

newswise.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Canada's flagship cardiac specialty center within the University Health Network, providing structural heart, complex valve, and heart failure programs—MHI's most direct Canadian peer in both clinical scope and public-payer model.

TypeDirect peer
Description

Dedicated cardiac specialty institute within Cedars-Sinai with strong structural heart, imaging, and research programs, including AI work in cardiovascular diagnostics—comparable in clinical depth and innovation focus.

TypeOthers
Description

Zurich-based provider of high-fidelity cardiovascular simulation systems that powers MHI's Advanced Simulation Centre; included as a key technology partner rather than a competitor, with comparable simulation-based cardiac training offerings sold to other institutions.

TypeBroad incumbent
Description

Harvard-affiliated academic medical center with a strong cardiovascular center and significant AI research in cardiac imaging; comparable as a research-driven peer institution in advanced cardiac care.

5Hôpital général de Montréal (McGill University Health Centre)
TypeRegional player
Description

McGill-affiliated Montreal academic hospital with cardiology services and a cardiac surgery program; operates in the same regional market and patient referral ecosystem as MHI.

TypeBroad incumbent
Description

Large academic medical center with leading cardiology and cardiothoracic surgery programs and active AI/digital health research in cardiac imaging—overlaps with MHI on the high-acuity cardiac and research dimensions.

TypeBroad incumbent
Description

Major U.S. academic medical center with a leading cardiology division, active cardiac AI research, and broad research collaborations; broader portfolio but a benchmark peer for high-acuity cardiac care and translational research.

TypeBroad incumbent
Description

Top-tier U.S. multi-specialty academic center whose cardiovascular division performs comparable high-acuity cardiac care, structural heart interventions, and AI-driven imaging research.

TypeRegional player
Description

Montreal-based academic health center offering cardiology services within a multi-specialty hospital under the same Quebec public-payer system as MHI; regional peer for patient catchment and policy environment.

TypeDirect peer
Description

Globally recognized specialty cardiac hospital with deep structural heart and valve programs, an international referral base, and a long-standing reputation for cardiology innovation—directly comparable in mission and clinical focus to MHI.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Montreal Heart Institute

Specialty Cardiac Hospital Servicesicm-mhi.org

The Montreal Heart Institute is a Montreal-based specialty cardiac hospital founded in 1954 that delivers clinical cardiology, structural heart interventions, and international specialist training through its first-in-Americas Advanced Simulation Centre, while conducting AI cardiac imaging research with UCSF.

What Montreal Heart Institute does

The Montreal Heart Institute (MHI) is a specialty cardiac hospital founded in 1954 in Montreal, Quebec, Canada, focused exclusively on cardiology, structural heart intervention, and cardiovascular research. It serves three primary customer segments: valve disease and structural heart patients receiving direct clinical care; international heart surgeons and specialists trained at its newly opened Advanced Simulation Centre; and women with cardiovascular health needs served through its dedicated Women's Heart Health Fund.

MHI's core offerings span three pillars. First, clinical care services including structural heart and valve therapy, cardiac imaging diagnostics, and emergency cardiac care delivered directly through its Montreal hospital facility. Second, specialist training via the Advanced Simulation Centre for Structural Heart and Valve Therapy — the first such facility in the Americas — which uses high-fidelity Simulands cardiovascular simulation systems to train 40-50 international specialists annually without patient risk. Third, research and innovation, notably a multiview deep neural network architecture co-developed with UCSF for echocardiogram analysis, published in Nature Cardiovascular Research, which demonstrated superior diagnostic accuracy versus single-view AI approaches.

MHI's business model is primarily a fee-for-service healthcare provider operating within the Quebec healthcare system, supplemented by philanthropic fundraising through the Montreal Heart Institute Foundation (including the $25M Women's Heart Health Fund target by 2030) and academic/government research grants. Revenue model details are not publicly disclosed, consistent with a healthcare institution. The institute distributes services regionally to patients in Quebec and globally through its international training program. MHI holds a "for-profit" classification in source data but functions as a specialty hospital with associated foundation-driven fundraising.

Montreal Heart Institute firmographics

Firmographics
Name
Montreal Heart Institute
Website
https://icm-mhi.org
Company type
Private
Founded year
1954
Operating status
Operating
Headcount range
251–500 employees
Short description
The Montreal Heart Institute is a Montreal-based specialty cardiac hospital founded in 1954 that delivers clinical cardiology, structural heart interventions, and international specialist training through its first-in-Americas Advanced Simulation Centre, while conducting AI cardiac imaging research with UCSF.
Ownership category
akta.pro rank

Montreal Heart Institute industry classification

Industry
Product category
Specialty Cardiac Hospital Services
NAICS
Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Diagnostic Imaging Centers (621512)
SIC
Services-Hospitals (8060), Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-General Medical & Surgical Hospitals, Nec (8062)
akta.pro primary industry
Cardiac & Cardiothoracic Specialty Hospitals (HLAFAHAA)
akta.pro secondary industries
Interventional Cardiology (PCI/Structural Heart) (HLAKABAB), Non-Invasive Cardiac Imaging (Echo/CT/MRI/Nuclear) (HLAKABAE), Cardiovascular / Cath Lab & Electrophysiology Centers (HLAFAIAI), Ambulatory Cardiology Diagnostic & Procedure Centers (Non-hospital-based) (HLAFABAK), Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT) (HLAHAFAI), General Cardiology (Consultative) (HLAKABAA)

Keywords

  • Cardiac care services
  • Structural heart therapy
  • Cardiovascular research
  • Specialist medical training
  • Cardiac imaging diagnostics

Where Montreal Heart Institute is headquartered

Location

Headquarters

HQ city
Montréal
HQ country
Canada
HQ region
North America

Offices1 record

Markets served

Montreal Heart Institute business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Others

Distribution channels2 records

Marketing channels2 records

Montreal Heart Institute product offering

Product offering

Core offering

Montreal Heart Institute is a specialty cardiac hospital founded in 1954 that delivers comprehensive cardiovascular care, structural heart and valve therapy, and operates the first Advanced Simulation Centre for Structural Heart and Valve Therapy in the Americas for training heart specialists. The institute also conducts AI-driven cardiac imaging research through a multiview deep neural network developed in collaboration with UCSF, and channels donor funding through its foundation into clinical innovation for women's heart health.

Product overview

The Montreal Heart Institute is a cardiac care and research center that offers specialized medical services including cardiac imaging diagnostics, structural heart and valve therapy, and cardiovascular research. The institution operates the Advanced Simulation Centre for Structural Heart and Valve Therapy (first in the Americas) for specialist training, and conducts AI research collaboration for cardiac imaging analysis. The Montreal Heart Institute Foundation supports the Women's Heart Health Fund for women's cardiovascular care research and treatment. The portfolio consists of clinical care services, specialized training facilities, and AI-powered diagnostic tools.

Differentiator

Problem solved

Functional benefit

Products and services

  • Cardiac Care Services

Quantifiable outcome

  • 20% increase in cardiac-related emergency cases during playoff games
  • +2 more outcomes

Companies that use Montreal Heart Institute

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Montreal Heart Institute technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature2 records

Montreal Heart Institute partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • SimulandscoreTechnology or Integration · 27 February 2026Zurich-based Simulands provides high-fidelity cardiovascular simulation systems for the Advanced Simulation Centre for Structural Heart and Valve Therapy at MHI. This technology enables immersive training for specialists in structural heart interventions without risk to patients.
  • UC San FranciscocoreStrategic or Co-development PartnerCollaborative research partnership with UCSF on developing multiview deep neural network architecture for cardiac imaging analysis. The study published in Nature Cardiovascular Research compared data from both institutions, with MHI providing cardiac imaging data to validate the AI diagnostic approach.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Montreal Heart Institute competitors and assessment

Company assessment

Direct peers

  • Toronto General Hospital — Peter Munk Cardiac Centre: Canada's flagship cardiac specialty center within the University Health Network, providing structural heart, complex valve, and heart failure programs—MHI's most direct Canadian peer in both clinical scope and public-payer model.
  • Cedars-Sinai Smidt Heart Institute: Dedicated cardiac specialty institute within Cedars-Sinai with strong structural heart, imaging, and research programs, including AI work in cardiovascular diagnostics—comparable in clinical depth and innovation focus.
  • Cleveland Clinic: Globally recognized specialty cardiac hospital with deep structural heart and valve programs, an international referral base, and a long-standing reputation for cardiology innovation—directly comparable in mission and clinical focus to MHI.

Others

  • Simulands: Zurich-based provider of high-fidelity cardiovascular simulation systems that powers MHI's Advanced Simulation Centre; included as a key technology partner rather than a competitor, with comparable simulation-based cardiac training offerings sold to other institutions.

Broad incumbents

  • Brigham and Women's Hospital: Harvard-affiliated academic medical center with a strong cardiovascular center and significant AI research in cardiac imaging; comparable as a research-driven peer institution in advanced cardiac care.
  • NewYork-Presbyterian Hospital: Large academic medical center with leading cardiology and cardiothoracic surgery programs and active AI/digital health research in cardiac imaging—overlaps with MHI on the high-acuity cardiac and research dimensions.
  • Massachusetts General Hospital (Mass General Brigham): Major U.S. academic medical center with a leading cardiology division, active cardiac AI research, and broad research collaborations; broader portfolio but a benchmark peer for high-acuity cardiac care and translational research.
  • Mayo Clinic Cardiovascular: Top-tier U.S. multi-specialty academic center whose cardiovascular division performs comparable high-acuity cardiac care, structural heart interventions, and AI-driven imaging research.

Regional players

  • Hôpital général de Montréal (McGill University Health Centre): McGill-affiliated Montreal academic hospital with cardiology services and a cardiac surgery program; operates in the same regional market and patient referral ecosystem as MHI.
  • Centre hospitalier de l'Université de Montréal (CHUM): Montreal-based academic health center offering cardiology services within a multi-specialty hospital under the same Quebec public-payer system as MHI; regional peer for patient catchment and policy environment.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Montreal Heart Institute social profiles

Digital presence

Montreal Heart Institute financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Montreal Heart Institute leadership team

Management profile

Number of profiles

Profiles3 records

Montreal Heart Institute funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Montreal Heart Institute M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Montreal Heart Institute

What does Montreal Heart Institute do?

Montreal Heart Institute is a specialty cardiac hospital founded in 1954 that delivers comprehensive cardiovascular care, structural heart and valve therapy, and operates the first Advanced Simulation Centre for Structural Heart and Valve Therapy in the Americas for training heart specialists. The institute also conducts AI-driven cardiac imaging research through a multiview deep neural network developed in collaboration with UCSF, and channels donor funding through its foundation into clinical innovation for women's heart health.

Is Montreal Heart Institute a public or private company?

Montreal Heart Institute is a private company. It is classified as unknown and is currently operating.

When was Montreal Heart Institute founded?

Montreal Heart Institute was founded in 1954. It employs 251 to 500 people.

Where is Montreal Heart Institute based?

Montreal Heart Institute is headquartered in Montréal, Canada, in the North America region.

Who are Montreal Heart Institute's main competitors?

Direct peers on record are Toronto General Hospital — Peter Munk Cardiac Centre, Cedars-Sinai Smidt Heart Institute and Cleveland Clinic. Simulands is listed as an others. Broad incumbents are Brigham and Women's Hospital, NewYork-Presbyterian Hospital, Massachusetts General Hospital (Mass General Brigham) and Mayo Clinic Cardiovascular. Regional players are Hôpital général de Montréal (McGill University Health Centre) and Centre hospitalier de l'Université de Montréal (CHUM).

Does Montreal Heart Institute have an API?

No public API is recorded for Montreal Heart Institute.

What industry is Montreal Heart Institute in?

Montreal Heart Institute's product category is Specialty Cardiac Hospital Services. Its primary akta.pro industry code is HLAFAHAA, Cardiac & Cardiothoracic Specialty Hospitals, with a secondary code of HLAKABAB, Interventional Cardiology (PCI/Structural Heart). Its NAICS code is 622310 and its SIC code is 8060.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Stock TitanMilestone Pharma Enrolls First Canadian AFib Trial PatientMilestone Pharmaceuticals announced that the Montreal Heart Institute enrolled its first patient in the ReVeRA-301 Phase 3 trial for etripamil nasal spray in AFib-RVR. The trial targets 150 patients, and Milestone is pursuing a single-study supplemental new drug application for this indication.NewswireJacques Goulet Named Chair of the Montreal Heart Institute Foundation's Board of DirectorsJacques Goulet, executive vice-president and chief risk officer at Sun Life, was appointed chair of the Montreal Heart Institute Foundation's board of directors. He has served on the board since 2019 and will succeed Daniel Lamarre, who remains on the board. The foundation has raised over $450 million since its founding.Global NewsEmergency rooms are getting some relief during Habs games in Stanley Cup playoffs - MontrealMontreal-area hospitals report a measurable decline in emergency room visits during Montreal Canadiens playoff games, with the McGill University Health Centre noting fewer patients at its teaching hospitals. A 2011 Canadian study found ER visits in Ontario fell by 17 percent during major hockey events, and Santé Québec reports roughly 100 fewer patients on average per game night across Quebec regions. The Montreal Heart Institute, however, reports a roughly 20 percent increase in cardiac-related emergency cases during playoff games, highlighting potential health risks associated with the emotional intensity of watching high-stakes hockey.NewswireA major milestone in Quebec that will improve the odds of transplant candidates receiving a donor heartThe Montreal Heart Institute and CHU Sainte-Justine will debut the TransMedics Organ Care System Heart, a device that preserves donor hearts under near-physiological conditions. This expands the donor pool and reduces wait times, as Quebec candidates average 204 days on a list, with 67 heart-transplant waits in 2025.NewswireThe Montreal Heart Institute Foundation Appoints Karl Blackburn as its President and Chief Executive OfficerThe Montreal Heart Institute Foundation appointed Karl Blackburn as president and CEO, effective April 21. Blackburn previously led the Conseil du patronat du Québec and has experience in economics and public affairs. The board thanked Alain Gignac for his contributions during the transition.NewswiseMultiview AI Approach Improves Diagnostic Accuracy in Cardiac ImagingResearchers from UC San Francisco developed a new "multiview" deep neural network architecture that analyzes multiple 2D imaging views simultaneously from echocardiograms, improving diagnostic accuracy for cardiovascular conditions compared to single-view AI approaches. In a study published in Nature Cardiovascular Research comparing data from UCSF and the Montreal Heart Institute, the multiview DNNs outperformed both single-view DNNs and computationally cheaper ensemble averaging of multiple single-view models for detecting left and right ventricular abnormalities, diastolic dysfunction, and valvular regurgitation. The researchers suggest this architecture can be applied to other medical imaging modalities where multiple views contain complementary diagnostic information.NewswireThe Montreal Heart Institute has opened an Advanced Simulation Centre for Structural Heart and Valve Therapy, a first in the AmericasThe Montreal Heart Institute (MHI) has opened the first Advanced Simulation Centre for Structural Heart and Valve Therapy in the Americas, using high-fidelity cardiovascular simulation systems from Zurich-based Simulands to train specialists in structural heart interventions. The centre aims to double the number of valve disease patients MHI can treat by 2028 through accelerated training and standardized practices, with plans to train 40 to 50 international specialists annually. A first group of heart surgeons from Brazil and Puerto Rico has already begun immersive training at the facility.NewswireClosing the gap, beat by beat: A $25 M fund for women's heart healthThe Montreal Heart Institute Foundation launched the Women's Heart Health Fund, an initiative to raise $25 million by 2030 to accelerate research and clinical innovations in women's cardiac care. Heart disease is the leading cause of premature death for women in Canada, claiming over 25,000 lives annually, yet women represent only about 30% of cardiology clinical trial participants. The fund will enable the Montreal Heart Institute to enroll more women in research, adapt treatments to their unique characteristics, develop prevention programs, and train the next generation of scientists.GlobeNewswireThe Montreal Heart Institute Welcomes FDA Approval of Colchicine for the Treatment of Cardiovascular DiseasesThe Montreal Heart Institute welcomed FDA approval of low-dose colchicine for cardiovascular prevention. The COLCOT study showed a 23% reduction in new ischemic events and 34% in total ischemic events after myocardial infarction, while LoDoCo-2 showed a 31% reduction in stable atherosclerotic disease.GlobeNewswireNational study suggests it’s time to rethink how we treat atrial fibrillationResearchers from the Montreal Heart Institute presented data from the EARLY-AF trial, published in the New England Journal of Medicine, showing that first-line catheter ablation is more effective than antiarrhythmic drugs at preventing atrial fibrillation progression. Patients treated with cryoablation were 75% less likely to progress to persistent AF and had a 69% reduction in hospitalizations over three years.